Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Clinical trial NCT03242967 · WITHDRAWN
Trial details
- NCT number
- NCT03242967
- Sponsor
- Akebia Therapeutics
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2018-02-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.